If you deal with recurrent UTIs, a new FDA-approved antibiotic called Blujepa could offer another treatment option—especially ...

Medically reviewed by Cordelia Nwankwo, MD An uncomplicated urinary tract infection (UTI) can sometimes go away on its own ...

On March 25, the U.S. Food and Drug Administration (FDA) approved the first new antibiotic to treat UTIs in 30 years. The ...

Science X is a network of high quality websites with most complete and comprehensive daily coverage of the full sweep of ...

The drug Blujepa, from drugmaker GSK, provides a new treatment option as bacteria increasingly become resistant to the ...

In all instances, you may require additional testing and treatment. You may continue to have symptoms after finishing a course of antibiotics for a UTI for a few reasons. Your infection may be ...

In complicated cases or if treatment has failed ... In uncomplicated cases, urinary tract infections are easily treated with a short course of antibiotics, although resistance to many of the ...

For children with febrile urinary tract infection (UTI), stopping antibiotic treatment 3 days after clinical improvement ...

it remains in contact with the upper urinary tract longer, increasing its effectiveness. After diagnosis of a low-grade UTUC, treatment plans include an induction course of six weekly doses ...

As I perused the latest edition of Georgetown’s leading publication — the Stall Seat Journal — I was pleased to see a brief ...

Although the long-term sequelae from UTI-related scarring has been debated, prompt diagnosis and institution of effective treatment remain a clinical priority. Because the clinical presentation of ...

If successful, it could become a multi-purpose treatment option in the fight against resistant bacterial infections. The approval of Blujepa marks a major breakthrough in UTI treatment ...